Although the exact molecular pathogenetic mechanisms in these schwannomas remain to be elucidated, a 4-hit/3-step mechanism involving SMARCB1 and NF2 genes seems to underlie development of these benign tumors in schwannomatosis patients10. This evidence concerns the gene NF2 and schwannoma.